LOXLEVIQ Trademark

Trademark Overview

On Friday, January 1, 2016, a trademark application was filed for LOXLEVIQ with the United States Patent and Trademark Office. The USPTO has given the LOXLEVIQ trademark a serial number of 86863691. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 30, 2026. This trademark is owned by Gilead Sciences Ireland UC. The LOXLEVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis

General Information

Serial Number86863691
Word MarkLOXLEVIQ
Filing DateFriday, January 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 30, 2026
Registration Number5802983
Registration DateTuesday, July 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 30, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, January 5, 2016NEW APPLICATION ENTERED
Tuesday, January 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 5, 2016ASSIGNED TO EXAMINER
Wednesday, April 6, 2016SUSPENSION LETTER WRITTEN
Wednesday, April 6, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, April 6, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 28, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 12, 2016ASSIGNED TO LIE
Friday, May 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 22, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2016SOU EXTENSION 1 FILED
Thursday, December 22, 2016SOU EXTENSION 1 GRANTED
Saturday, December 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017SOU EXTENSION 2 FILED
Tuesday, July 11, 2017SOU EXTENSION 2 GRANTED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2017SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2017SOU EXTENSION 3 FILED
Thursday, December 14, 2017SOU EXTENSION 3 GRANTED
Saturday, December 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 29, 2018SOU EXTENSION 4 FILED
Friday, June 29, 2018SOU EXTENSION 4 GRANTED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, January 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 17, 2018SOU EXTENSION 5 FILED
Wednesday, January 2, 2019SOU EXTENSION 5 GRANTED
Thursday, January 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2019TEAS DELETE 1(B) BASIS RECEIVED
Friday, May 24, 2019NOTICE OF ALLOWANCE CANCELLED
Friday, June 7, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 30, 2026CANCELLED SEC. 8 (6-YR)

Related Keywords

loxleviq preparations pharmaceutical treatment diseases anti infectious fibrotic prevention myeloma hepatitis